TD

(redirected from travelers' diarrhea)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

TD

The two-character ISO 3166 country code for CHAD.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

TD

1. ISO 3166-1 alpha-2 code for the Republic of Chad. This is the code used in international transactions to and from bank accounts in Chad.

2. ISO 3166-2 geocode for Chad. This is used as an international standard for shipping to Chad. Each region in Chad has its own code with the prefix "TD." For example, the code for the Region of Batha is ISO 3166-2:TD-BA.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved
References in periodicals archive ?
"The widespread use of ciprofloxacin and other antibiotics for travelers' diarrhea has contributed to the rise of these resistant bacteria," Dr.
Use of bismuth subsalicylate for the prevention of Travelers' Diarrhea. Reviews of Infectious Diseases 1990; 12(Suppl 1): S64-S68.
The chances that you or your child get travelers' diarrhea depend on a number of factors, the most important being your travel destination:
Travelers' diarrhea (TD) is the most common illness affecting travelers.
Contrary to popular opinion, a preemptive strike with antibiotics won't prevent travelers' diarrhea. "Don't even bother," she advised.
To resolve some of these questions, the NIH Office of Medical Applications of Research and the National Institute of Allergy and Infectious Diseases convened a Consensus Development Conference on Travelers' Diarrhea on January 28-30, 1985.
She wonders what she might do to prevent travelers' diarrhea. Her only medical problem is rheumatoid arthritis, which has been well controlled with methotrexate.
Travelers' diarrhea remains a major public health problem, causing substantial illness and disability.
The first priority in any travel health consultation should focus on the easiest and most effective way to avoid the most common illness: travelers' diarrhea. "Don't drink tap water and don't eat fruits and vegetables that have been rinsed under tap water is the best advice you can give," he said.
Biopharmaceutical company Santarus Inc (NASDAQ:SNTS) said on Wednesday that the company has begun to enroll patients for its Phase III clinical programme to evaluate the efficacy and safety of rifamycin SV MMX for the treatment of patients with travelers' diarrhea.
30 December 2009 - US-based biopharmaceutical company Santarus Inc (NASDAQ: SNTS) announced today it has submitted an Investigational New Drug (IND) application with the FDA requesting approval to begin a Phase III clinical trial evaluating rifamycin SV MMX in patients with travelers' diarrhea.